scholarly article | Q13442814 |
P2093 | author name string | Takashi Tsuruo | |
Hiroichi Nagai | |||
Naoki Inagaki | |||
Makoto Murakami | |||
Ichiro Kudo | |||
Hyeun Wook Chang | |||
Mikihiko Naito | |||
Satoko Shimbara | |||
Kumiko Yoshihara | |||
Masatsugu Sawada | |||
Tae Churl Moon | |||
P2860 | cites work | Cloning and characterization of novel mouse and human secretory phospholipase A(2)s | Q22003814 |
Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s | Q22253225 | ||
Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis | Q22254717 | ||
Cyclooxygenase regulates angiogenesis induced by colon cancer cells | Q24336248 | ||
Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2 | Q28115215 | ||
Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cells | Q28146023 | ||
Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms | Q28564979 | ||
The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 | Q28565225 | ||
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice | Q28585868 | ||
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 | Q28585904 | ||
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 | ||
On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes | Q28592582 | ||
Receptors for a growing family of secreted phospholipases A2. | Q33633078 | ||
Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells | Q33908899 | ||
SPLASH (PLA2IID), a novel member of phospholipase A2 family, is associated with lymphotoxin deficiency | Q33934414 | ||
Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins | Q34083759 | ||
Diversity and regulatory functions of mammalian secretory phospholipase A2s. | Q34212477 | ||
The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia | Q34313013 | ||
Different role of IL-4 in the onset of hapten-induced contact hypersensitivity in BALB/c and C57BL/6 mice | Q35041837 | ||
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential | Q36085224 | ||
Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2 | Q36164895 | ||
Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. | Q37384421 | ||
Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process | Q38321993 | ||
Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells | Q40917338 | ||
Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway | Q40924363 | ||
Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli | Q40932126 | ||
Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways | Q40978833 | ||
Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme | Q40993744 | ||
Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. | Q42604316 | ||
Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice | Q43479135 | ||
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells | Q43559615 | ||
An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium | Q44872907 | ||
Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells | Q46096426 | ||
Potential role of group X secretory phospholipase A(2) in cyclooxygenase-2-dependent PGE(2) formation during colon tumorigenesis. | Q53402628 | ||
Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. | Q54707109 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colon carcinoma | Q18554829 |
mast cell | Q191989 | ||
P304 | page(s) | 2698-2707 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | FEBS Journal | Q1388041 |
P1476 | title | Group IID heparin-binding secretory phospholipase A(2) is expressed in human colon carcinoma cells and human mast cells and up-regulated in mouse inflammatory tissues | |
P478 | volume | 269 |